Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures

In an analysis of risk evaluation and mitigation strategies for teratogenic drugs, Ameet Sarpatwari, Beatrice Brown and Aaron Kesselheim explore the variation in primary and secondary prevention measures.

Automated summary

In this analysis, the authors, Ameet Sarpatwari, Beatrice Brown, and Aaron Kesselheim, examine the differences in primary and secondary prevention measures for teratogenic drugs.